Asia-Pacific Autoimmune Disease Diagnostics Market Expected to Reach @marketSize @valueUnit by 2033
The Asia-Pacific autoimmune disease diagnostics market is booming, projected to reach $1.24 billion by 2025 and grow at a CAGR of 5.96% until 2033. Driven by rising prevalence of autoimmune diseases, this market offers significant opportunities for companies like Bio-Rad, Roche, and Abbott, particularly in key markets such as China, Japan, and India. Explore the latest market trends and growth projections.